MF
BLUE

Magnetar Financial’s bluebird bio BLUE Stock Holding History

Magnetar Financial’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-618
Closed -$346K – 1049
2020
Q4 		$346K Buy
+618
New +$392K ﹤0.01% 610
2020
Q2 		– Sell
-1,604
Closed -$955K – 447
2020
Q1 		$955K Buy
1,604
+1,231
+330% +$1.2M 0.02% 191
2019
Q4 		$424K Buy
+373
New +$405K 0.01% 364
2018
Q2 		– Sell
-255
Closed -$564K – 507
2018
Q1 		$564K Buy
+255
New +$649K 0.01% 310

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Magnetar Financial's BLUE Position: Q1 2021 in Review

Magnetar Financial sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 618 shares — an estimated $346K sold.

Magnetar Financial first reported a position in BLUE in Q1 2018 and held it in 4 quarters. The position peaked at $955K in Q1 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Magnetar Financial reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Magnetar Financial sold 618 bluebird bio shares in Q1 2021, an estimated $346K.
  • Magnetar Financial first reported a position in bluebird bio in Q1 2018 and held it in 4 quarters.
  • Magnetar Financial's bluebird bio position peaked at $955K in Q1 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Magnetar Financial's 13F filing for Q1 2021, filed 14 May 2021.